Tuttavia, ci sono stati alcuni effetti collaterali lievi, tra cui nausea e fastidio allo stomaco 59, 60
Retatrutide is a triple agonist (GLP-1, GIP, and glucagon receptor) that has shown even more impressive weight loss results in early trials
It is studied in preclinical and laboratory models for its role in metabolic and endocrine pathway research
Referral to endocrinology, urology, gynecology, or sexual medicine specialists may be appropriate for complex cases requiring specialized evaluation and management
Injection frequency : Once weekly Dosage : 2.4 mg semaglutide in 0.5 mL Administration sites : Abdomen, thigh, or upper arm Injection device : Disposable FlexTouch pen Missed dose : Administer within 5 days
If this roundup gave you some new meal ideas, you're going to love The PSQ Cookbook